-
Aculys Pharma and Medical Note enter into a partnership to raise awareness on sleep disorders
-
Aculys Pharma joins the Sleep Services Consortium of Japan
-
Aculys Pharma Initiates a Phase 3 Trial of pitolisant Treating Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea Syndrome
-
Aculys Pharma and Four H Initiate Research Collaboration using Wearable Devices to Study Sleep Disorders in Japan
-
Aculys Pharma initiates a phase 3 clinical study of a diazepam nasal spray: an antiepileptic drug for the treatment of epileptic seizures
-
Aculys Pharma initiates a phase 3 clinical study of the histamine H3 receptor antagonist/inverse agonist pitolisant in patients with narcolepsy in Japan
-
Aculys Pharma has entered into a comprehensive collaboration agreement with KNOCK ON THE DOOR to solve social issues related to recurrent epileptic seizures
-
Aculys Pharma and SUSMED have entered into a contract to conduct the world’s first clinical trial utilizing blockchain technology
-
Aculys Pharma initiates collaboration with Ubie with the aim of building a “sleep ecosystem”
-
Aculys Pharma Closes US$24 Million Series B Financing
